J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO
J&J has found its next big cancer drug. In China.
The pharma giant has agreed to pay $350 million upfront to partner with Legend Biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
